Based on years of grant-funded R&D and protected by 6 issued and 2 pending patents, the AQ Shunt competes in the growing $5B surgical glaucoma treatment market.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free